|
Core |
HBV |
Steatosis |
Perlemuter et al. 2002 [25] |
|
|
HCC |
Moriya et al. 1998 [29] |
|
|
Oxidative stress |
Moriya et al. 2001 [30] |
|
|
Alteration of cytokine expression |
Tsutsumi et al. 2002 [41] |
|
|
Activation of retinoid X receptor alpha |
Tsutsumi et al. 2002 [46] |
|
|
Steatosis, HCC |
Moriishi et al. 2007 [26] |
|
|
|
Tanaka et al. 2008 [49] |
|
|
|
Tanaka et al. 2008 [50] |
|
EF-1α |
Oxidative stress |
Machida et al. 2006 [53] |
|
Core-E1-E2 |
Albumin |
Steatosis, HCC |
Lerat et al. 2002 [32] |
|
|
HCC |
Kamegaya et al. 2005 [34] |
|
|
Oxidative stress |
Okuda et al. 2002 [54] |
|
|
|
Korenaga et al. 2005 [55] |
|
CMV |
Steatosis, HCC |
Naas et al. 2005 [92] |
|
Core-E1-E2-NS2 |
Cre-loxP system |
Hepatitis, Cellular immune responses |
Wakita et al. 1998 [61] |
|
|
|
Wakita et al. 2000 [62] |
|
|
Suppression of Fas-mediated cell death |
Machida et al. 2001 [63] |
|
Polyprotein |
Alpha1 antitrypsin |
Steatosis, intrahepatic |
Alonzi et al. 2004 [93] |
|
|
T cell recruitment |
|
|
Albumin |
Steatosis, HCC |
Lerat et al. 2002 [32] |
|
|
Impairment of cellular immune response |
Disson et al. 2004 [59] |